Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Cheng Guo Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0762-8496; OpenAlex author ID A5008550039. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers

Papers 3

  1. LncRNA LOXL1-AS1/miR-28-5p/SEMA7A axis facilitates pancreatic cancer progression. First author DOI 10.1002/cbf.3449↗
  2. LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway. Co-author DOI 10.1186/s12935-020-01366-w↗
  3. Chinese Herbal Medicines as an Adjunctive Therapy for Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis. Last author DOI 10.1155/2015/350730↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Liping Wu · 2 shared papers, 2020 · strength 0.32
  2. Yongcun Liu · 2 shared papers, 2020 · strength 0.32
  3. Yuan Shao · 1 shared paper, 2020 · strength 0.16
  4. Bin Li · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.